The allosteric mTORC1 inhibitor rapamycin has been shown to revert Akt-dependent early prostate intraepithelial neoplasia (PIN) in young mice through regulation of apoptotic and HIF-1-dependent pathways[93]. The gene discussed is HIF1A; the disease is prostate intraepithelial neoplasia.